$1.8 billion new US facility a 'huge step strategically and financially' for Novo Nordisk
Novo Nordisk to buy sickle cell disease biotech Forma Therapeutics in $1.1B deal - MedCity News
Novo Nordisk strengthens executive team with new appointments | EuropaWire.eu | The European Union's press release distribution & newswire service
Prepared by Imprima - Novo Nordisk 6K
Erik Hageman is one of Denmark's longest-living people with type 1 diabetes. He was diagnosed at the age of two and is still go
Novo Nordisk Throws Its Weight Behind Patients With Obesity And Diabetes | Neuberger Berman
Novo Nordisk - Wikipedia
Laboratoire Novo Nordisk - La Défense, Île-de-France
Novo Nordisk's Rybelsus (semaglutide) Receives FDA's Approval as the First Oral GLP-1 analog for Type 2 Diabetes
Novo Nordisk (NVO): Overvalued Pharma That Should Be Rotated Here | Seeking Alpha
Novo Nordisk - Class B Shares (NOVO B) Dividends
Novo Nordisk Stock: Some Changes, But No Changes In Thesis (NYSE:NVO) | Seeking Alpha
Q&A: Novo Nordisk's Keith Middleton on its latest DE&I efforts
Watch Stocks to Watch in Europe: GSK, Novartis, Novo Nordisk, BBVA, Entain - Bloomberg
Novo Nordisk 2018: Struggling against the tide – PharmaLive
Novo Nordisk agrees $100 million settlement of US securities class act
MEDIA B-ROLL : Sites and buildings
Novo Nordisk plots $1.3B in spending as it expands API production—and advances new oral meds | Fierce Pharma
NOVOB: Novo Nordisk A/S Stock Price Quote - Copenhagen - Bloomberg
